FDA OK's Ozempic to protect kidneys in type 2 diabetes patients
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for kidney failure.
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
F.D.A. Approves Ozempic to Treat Kidney Disease
The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding use in U.S.
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, prevent death from cardiovascular disease,
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.
FDA clears use of Ozempic to protect kidney health
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.
FDA OKs Ozempic for diabetic kidney disease
The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure and cardiovascular-related death in adults with Type 2 diabetes and chronic kidney disease. This new approval expands Ozempic's use,
Medical News Today1d
Calorie restriction plus common diabetes drug leads to higher remission rates
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
Combination of medication, diet could reverse type 2 diabetes, study finds
A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...
Rolling Out1d
A game-changing discovery in diabetes treatment
A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...
Knowridge9d
New way to improve insulin secretion in type 2 diabetes
Researchers from Lund University, in collaboration with Newcastle University, have uncovered a potential breakthrough in ...
Endocrinology Advisor1d
SGLT-2 Inhibitors Reduce Liver Cirrhosis Risk in Type 2 Diabetes
SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
Rolling Out3d
Breakthrough diabetes drug slashes dementia risk by 35%
New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...
Three symptoms of type 2 diabetes can start the second you get into bed to sleep
Type 2 diabetes causes a person's blood sugar level to become too high, and can often lead to more serious health conditions ...
Hosted on MSN3h
Nutrient Deficiencies Common in People with Type 2 Diabetes
Two people have already died from the bacterial infectious disease. The outbreak could be one of the largest in the history ...